EyExam
AI-based Solution for the Diagnosis of Eye Diseases
Health Tech & Life Sciences
Non Active, Jun 2020 ceased to operate
Company Overview
Snapshot
Founded in July 2019 by Tamar Levi Vineberg, EyExam operated with 1–10 employees. The company ceased operations in June 2020, having been in a pre-funding stage.
Business overview
EyExam developed an AI-based solution for the diagnosis and tracking of eye diseases, including age-related macular degeneration and diabetic retinopathy. The company's core technology analyzed optical coherence tomography (OCT) images to provide detailed diagnoses, urgency of care assessments, biomarker identification, and treatment recommendations. EyExam focused on the digital healthcare market, serving the Health Tech & Life Sciences sector with a B2B business model.
Company Intelligence Q&A
- What is EyExam's primary focus?
- EyExam focuses on providing an accessible and affordable AI-based solution for diagnosing and tracking eye diseases such as age-related macular degeneration and diabetic retinopathy.
- When was EyExam founded?
- EyExam was founded in July 2019.
- What technology does EyExam utilize?
- EyExam utilizes an AI-based solution to analyze optical coherence tomography (OCT) images.
- What services does EyExam's solution provide?
- EyExam's solution delivers detailed diagnoses, including urgency of care, biomarkers, and recommended treatment, within seconds of analyzing OCT images.
- What is the current operational status of EyExam?
- EyExam ceased to operate in June 2020.